✦ LIBER ✦

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients

✍ Scribed by Teresa Mele; Daniele Generali; Stephen Fox; Maria Pia Brizzi; Alessandra Bersiga; Manuela Milani; Giovanni Allevi; Simone Bonardi; Sergio Aguggini; Marco Volante; Luigi Dogliotti; Alberto Bottini; Adrian Harris; Alfredo Berruti

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 681 KB
Volume: 123
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1063-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of tamoxifen on serum lipid and

Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer

✍ Manuel Morales; Norberto Santana; Adela Soria; Alicia Mosquera; José Ordovás; Ja 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 503 KB

Clinical pharmacology of tamoxifen in pa

Clinical pharmacology of tamoxifen in patients with breast cancer: Correlation with clinical data

✍ Carol Fabian; Larry Sternson; Moustafa El-serafi; Lyn Cain; Erwin Hearne 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

The association of nonalcoholic steatohe

The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer

✍ Tom Saphner; Shirley Triest-Robertson; Hailun Li; Paul Holzman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

Endoxifen (4-hydroxy-N-desmethyl-tamoxif

Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen

✍ Young Chai Lim; Zeruesenay Desta; David A. Flockhart; Todd C. Skaar 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 307 KB

Combined endocrine effects of LHRH agoni

Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer

✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment

Effect of tamoxifen on serum cholesterol

Effect of tamoxifen on serum cholesterol in Japanese women with breast cancer

✍ Shigeru Imoto 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 404 KB